Literature DB >> 447439

Pharmacokinetics of terbutaline after subcutaneous administration.

J G Leferink, H Lamont, I Wagemaker-Engels, R A Maes, R Pouwels, M van der Straeten.   

Abstract

The pharmacokinetics of terbutaline has been studied after subcutaneous adminsitration of a therapeutic dose of 250 microgram in 14 patients. Short absorption half-lives of about 7 min resulted in a fast uptake of the drug. Serum concentrations of terbutaline were measured up to 10 hr after administration, depending on the individual. An open one-compartment model appeared adequate for the mathematical description of the kinetics in most patients. Elimination constants of 0.27 +/- 0.07 hr-1 were observed. The elimination process was biphasic in 5 patients with a mean elimination constant of the second phase of 0.10 +/- 0.04 hr-1. This resulted in a comparatively high concentration of 0.7 ng/ml 10 hr after administration. Regular use of terbutaline did not influence the pharmacokinetic data in a significant way.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447439

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


  3 in total

Review 1.  Pharmacokinetics of tocolytic agents.

Authors:  Vassilis Tsatsaris; Dominique Cabrol; Bruno Carbonne
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Terbutaline pharmacokinetics in cows: preliminary data.

Authors:  Melanie J Boileau; Kevin E Washburn; Cyril R Clarke; Robert N Streeter; Lara K Maxwell
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

Review 3.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.